Company / Return on Assets (ROA)
Sarepta Therapeutics Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-21.3%
FY2025
5-year range
-21.3% / 5.9%
FY2021-FY2025
Trend
-458.6%
vs FY2024
Sector context
#105 of 213
Health Care
What the data says
Return on Assets (ROA) changed -459% YoY in FY2025, a notable deviation from the 9-year average annual change of -109%.
Based on SEC 10-K filings.
-21.3% in FY2025 with a 5-year CAGR of -9.2%.
Declined from -16.4% to -21.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -3.6pp
- 5-Year Change
- -9.2pp
- 10-Year Change
- -
Sector benchmark
#105 of 213 in Health CareTop 49% of 213This company -21.3% Sector average -24.1%
▼
+11.8% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 458.6% year-over-year.
- Currently 2.8pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -21.3% | -458.6% |
| FY2024 | 5.9% | +136.2% |
| FY2023 | -16.4% | +7.3% |
| FY2022 | -17.7% | -33.2% |
| FY2021 | -13.3% | -9.6% |
| FY2020 | -12.1% | -336.3% |
| FY2019 | -2.8% | +87.4% |
| FY2018 | -22.0% | -468.0% |
| FY2017 | -3.9% | +93.8% |
| FY2016 | -63.0% | +21.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026